Ispecimen Inc (ISPC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,275 | -10,488 | -5,486 | -2,706 | -1,658 |
| Depreciation Amortization | 136 | 1,731 | 1,323 | 865 | 433 |
| Accounts receivable | -85 | 1,337 | 1,310 | 1,055 | 752 |
| Accounts payable and accrued liabilities | -394 | 1,240 | 574 | 117 | -411 |
| Other Working Capital | -962 | 2,114 | 806 | 517 | 3 |
| Other Operating Activity | 219 | -174 | -1,850 | -1,137 | -214 |
| Operating Cash Flow | $-3,362 | $-4,241 | $-3,324 | $-1,288 | $-1,096 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -700 | -1,001 | -1,001 | -1 | N/A |
| Investing Cash Flow | $-700 | $-1,001 | $-1,001 | $-1 | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | 5,750 | 5,750 | N/A | N/A |
| Common Stock Repurchased | N/A | N/A | -521 | -1 | N/A |
| Other Financing Activity | 0 | 4,494 | 0 | 0 | 0 |
| Financing Cash Flow | $N/A | $10,244 | $5,229 | $-1 | $N/A |
| Beginning Cash Position | 6,881 | 1,878 | 1,878 | 1,878 | 1,878 |
| End Cash Position | 2,819 | 6,881 | 2,783 | 589 | 783 |
| Net Cash Flow | $-4,062 | $5,002 | $904 | $-1,290 | $-1,096 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,362 | -4,241 | -3,324 | -1,288 | -1,096 |
| Capital Expenditure | -700 | -1,001 | -1,001 | -1 | N/A |
| Free Cash Flow | -4,062 | -5,241 | -4,324 | -1,289 | -1,096 |